BE851278A - Preparations pharmaceutiques destinees a remedier a l'abus des stupefiants - Google Patents

Preparations pharmaceutiques destinees a remedier a l'abus des stupefiants

Info

Publication number
BE851278A
BE851278A BE174804A BE174804A BE851278A BE 851278 A BE851278 A BE 851278A BE 174804 A BE174804 A BE 174804A BE 174804 A BE174804 A BE 174804A BE 851278 A BE851278 A BE 851278A
Authority
BE
Belgium
Prior art keywords
narcotics
abuse
remedy
pharmaceutical preparations
preparations intended
Prior art date
Application number
BE174804A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BE851278A publication Critical patent/BE851278A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE174804A 1976-02-11 1977-02-10 Preparations pharmaceutiques destinees a remedier a l'abus des stupefiants BE851278A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65699676A 1976-02-11 1976-02-11

Publications (1)

Publication Number Publication Date
BE851278A true BE851278A (fr) 1977-08-10

Family

ID=24635439

Family Applications (1)

Application Number Title Priority Date Filing Date
BE174804A BE851278A (fr) 1976-02-11 1977-02-10 Preparations pharmaceutiques destinees a remedier a l'abus des stupefiants

Country Status (13)

Country Link
US (1) US4126684A (fr)
JP (1) JPS5299228A (fr)
AU (1) AU515341B2 (fr)
BE (1) BE851278A (fr)
CA (1) CA1069050A (fr)
DE (1) DE2705051A1 (fr)
FR (1) FR2340727A1 (fr)
GB (1) GB1567543A (fr)
IE (1) IE44562B1 (fr)
IL (1) IL51415A (fr)
NL (1) NL7701494A (fr)
PH (1) PH13312A (fr)
ZA (1) ZA77773B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457933A (en) * 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
NL8006135A (nl) * 1980-11-10 1982-06-01 Univ Erasmus Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1226800B (it) * 1988-09-16 1991-02-19 Prodotti Formenti Composizioni farmaceutiche orali contenenti sali di destrorfano.
FR2662354B1 (fr) * 1990-05-23 1994-10-07 Adir Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine.
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
ATE323491T1 (de) 1997-12-22 2006-05-15 Euro Celtique Sa Peroral zu verabreichende arzneiform enthaltend eine kombination von einem opioid agonisten und naltrexon
HU228771B1 (en) * 1998-05-15 2013-05-28 Warner Lambert Co Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
HU228772B1 (en) * 1998-05-15 2013-05-28 Warner Lambert Co Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
IT1313585B1 (it) * 1999-07-30 2002-09-09 Neuroscienze S C A R L Uso di agonisti dei recettori gabab per la terapia di mantenimentodell'astinenza da nicotina in soggetti nicotino-dipendenti.
ATE493130T1 (de) 2001-05-11 2011-01-15 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
ES2627298T3 (es) * 2002-04-05 2017-07-27 Mundipharma Pharmaceuticals S.L. Preparación farmacéutica que contiene oxicodona y naloxona
US20030199439A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
US7109239B2 (en) * 2003-08-20 2006-09-19 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
EP2354120A1 (fr) 2003-08-20 2011-08-10 XenoPort, Inc. Synthèse de promédicaments a base de carbamate d'acyloxyalkyle et leurs intermédiaires
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
EP1604667A1 (fr) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement des impatiences des membres inférieurs
EP1604666A1 (fr) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement de la bronchopneumopathie chronique obstructive
WO2006050471A2 (fr) 2004-11-03 2006-05-11 Xenoport, Inc. Prodrogues d'acyloxyalkyl carbamate de l'acide 3-aminopropylsulfinique, et procedes de synthese et d'utilisation
WO2006050472A2 (fr) * 2004-11-03 2006-05-11 Xenoport, Inc. Prodrogues d'acyloxyalkyl carbamate, et leurs procedes de synthese et d'utilisation
AP2274A (en) * 2005-01-28 2011-08-19 Euro Celtiques Sa Alcohol resistant dosage forms.
EP1702558A1 (fr) 2005-02-28 2006-09-20 Euro-Celtique S.A. Procédé et dispositif pour évaluer la fonction de l'activité intestinale
EP1695700A1 (fr) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Forme posologique contenant de l'oxycodone et de la naloxone
WO2008033572A1 (fr) * 2006-09-15 2008-03-20 Xenoport, Inc. Promédicaments à base de carbamate d'acyloxyalkyle, procédés de synthèse et utilisation
ES2365574T3 (es) * 2007-01-11 2011-10-07 Xenoport, Inc. Formas de dosificación oral para liberación continua de un profármaco de r-baclofeno y procedimientos de tratamiento.
TW200936123A (en) * 2007-11-06 2009-09-01 Xenoport Inc Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
WO2009094577A2 (fr) 2008-01-25 2009-07-30 Xenoport, Inc. Formes mésophasiques de précurseurs d'acide (3s)-aminométhyl-5-méthyl-hexanoïque et procédés d'utilisation
US7872046B2 (en) * 2008-01-25 2011-01-18 Xenoport, Inc. Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
TWI380812B (zh) * 2008-01-25 2013-01-01 Xenoport Inc （３ｓ）-胺甲基-５-甲基己酸前藥之晶形及使用方法
US20100137442A2 (en) * 2008-02-01 2010-06-03 Xenoport, Inc. Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment
WO2010017504A1 (fr) * 2008-08-07 2010-02-11 Xenoport, Inc. Procédés de synthèse de promédicaments de 1-(acyloxy)-alkylcarbamate
US7989641B2 (en) 2008-08-07 2011-08-02 Xenoport, Inc. Methods of synthesizing N-hydroxysuccinimidyl carbonates
KR20110117216A (ko) 2009-03-03 2011-10-26 제노포트 인코포레이티드 Ｒ-바클로펜 전구약물의 서방형 경구 투약 형태
KR20110133602A (ko) 2009-03-10 2011-12-13 유로-셀티큐 에스.에이. 옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
CA2758245A1 (fr) * 2009-04-17 2010-10-21 Xenoport, Inc. Derives d'acide gamma-aminobutyrique comme ligands des recepteurs gabab
WO2013023155A1 (fr) 2011-08-11 2013-02-14 Xenoport, Inc. Formes cristallines anhydres et hémihydratées d'un promédicament (r)-baclofène, procédés de synthèse et procédés d'utilisation
JP2016525138A (ja) 2013-07-23 2016-08-22 ユーロ−セルティーク エス．エイ． 疼痛および腸内ディスバイオシスをもたらす疾患および／または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ
JP6539274B2 (ja) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 押出成形された即放性乱用抑止性丸剤
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449645A (de) * 1963-07-09 1968-01-15 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions

Also Published As

Publication number Publication date
AU515341B2 (en) 1981-04-02
DE2705051A1 (de) 1977-08-18
ZA77773B (en) 1977-12-28
NL7701494A (nl) 1977-08-15
IE44562L (en) 1977-08-11
PH13312A (en) 1980-03-06
AU2217177A (en) 1978-08-17
IL51415A (en) 1979-11-30
IE44562B1 (en) 1982-01-13
CA1069050A (fr) 1980-01-01
GB1567543A (en) 1980-05-14
IL51415A0 (en) 1977-04-29
FR2340727A1 (fr) 1977-09-09
JPS5299228A (en) 1977-08-19
US4126684A (en) 1978-11-21

Similar Documents

Publication Publication Date Title
FR2340727A1 (fr) Preparations pharmaceutiques destinees a remedier a l'abus des stupefiants
IT1081933B (it) Dispositivo per l'inalazione di medicamenti in polvere
IT1081486B (it) Dispositivo per l'inalazione di medicamenti in polvere
LU90037I2 (fr) Konakion et ses dérivés pharmaceutiquement acceptables
BE858522A (fr) Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
BE871584A (fr) Preparations pharmaceutiques
SE7709359L (sv) Farmaceutisk doseringsform
DK454176A (da) Galeniske preparater
BE849102A (fr) Preparation a base de diethylaminoethyl-dextrane inhibant l'absorption des lipides
BE858608A (fr) Melanges contenant des polydiorganosiloxanes et leur preparation
FR2344291A1 (fr) Composition pour l'application topique d'un medicament
PL200094A1 (pl) Glowica filtrowa modulowa oraz zestaw filtrow
BE844532A (fr) Medicament a base d'un derive du benzothiadiazole
BE855287A (fr) Compositions pharmaceutiques et cosmetiques a base d'elastine
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
IT1082822B (it) Chinolil 4 3 propil 1 4 piperidine loro preparazione e loro utilizzazione
FR2319605A1 (fr) Preparation de melanges d'alkylnaphtalenes
BE858507A (fr) Medicament antagoniste de l'action de la gastrine et des polypeptides apparentes
BE853569A (nl) Medicinale preparaten
BE839258A (fr) Perfectionnements a la preparation d'alliages
BE859290A (fr) Preparation d'acides alpha-cetocarboxyliques aliphatiques et heterocycliques
FR2342067A1 (fr) Medicament a base d'un derive de la quinoleine
FR2347043A1 (fr) Medicament diuretique
FR2332254A1 (fr) Preparation d'un hydroxy-aldehyde
BE860526A (fr) Preparations pharmaceutiques contenant un derive de propanol et un tranquilisant mineur